Steve Bryson, PhD - Science Writer | Sarcoidosis News
Steve Bryson is a science writer for Sarcoidosis News with a PhD in biochemistry. He covers the latest news and information on a variety of sarcoidosis topics.| Sarcoidosis News
Steve Bryson is a science writer for Sarcoidosis News with a PhD in biochemistry. He covers the latest news and information on a variety of sarcoidosis topics.| Sarcoidosis News
Black women with sarcoidosis have a nearly twofold higher risk of kidney stones, with the odds increasing with metabolic conditions.| Sarcoidosis News
Read about how wide-ranging sarcoidosis symptoms are, and how they often affect the lungs but also can affect many other organs.| Sarcoidosis News
Among people with cardiac sarcoidosis on immunosuppressants, heart involvement alone linked with more serious events in a small study.| Sarcoidosis News
Category archive page for News.| Sarcoidosis News
Cardiac sarcoidosis is systemic sarcoidosis that affects the heart muscle, and raises the risk of arrhythmias and congestive heart failure.| Sarcoidosis News
I started writing this column a few weeks ago when I was angry. I was irate, it was festering, and I had to get it out. I started jotting down […] The post It’s OK to get angry when our best-laid plans go awry appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The test, which includes new echocardiography techniques and heart damage blood markers, was an improvement over the frequent HRS algorithm.| Sarcoidosis News
Tailored therapeutics for ocular sarcoidosis should start with glucocorticoids, followed by immunosuppressants and biologics, per a study.| Sarcoidosis News
Columnist Kerry Wong, defending her need for cheese, finds diet, exercise, and socializing choices should consider mental and emotional needs.| Sarcoidosis News
The risk of developing sarcoidosis in adulthood may be associated with microbial exposure in daily life during childhood, a study found.| Sarcoidosis News
The final participant has completed the last visit as part of EFZO-FIT, a Phase 3 clinical trial testing Atyr Pharma’s experimental treatment efzofitimod, in adults with pulmonary sarcoidosis. Top-line results are […] The post Final visit completed in Phase 3 EFZO-FIT clinical trial of efzofitimod appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The Foundation for Sarcoidosis Research (FSR) has awarded $450,000 to three scientists to support research projects related to sarcoidosis diagnosis, treatment, and care. This funding comes through FSR’s Early Career […] The post FSR awards 3 early career grants to advance sarcoidosis research appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
“When did the pain start?” That’s a fairly straightforward question with an uncomplicated answer for most people: “I fell last Thursday and hurt my knee.” “I was helping a friend […] The post Boiling frog syndrome: Symptoms of sarcoidosis turn up the heat appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Sinonasal sarcoidosis, when the disease affects the nasal cavity and the surrounding air-filled cavities called the sinuses, mainly affects women and manifests as nasal obstruction, according to a review study. […] The post Women more likely to develop sinonasal sarcoidosis: Review study appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The Foundation for Sarcoidosis Research (FSR) has launched an enhanced version of its patient registry, FSR-SARC, to help maximize the impact of patient participation in research. “Now in its tenth year, […] The post FSR launches enhanced version of its sarcoidosis patient registry appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Last week, my husband and I took a road trip to see the Yankees play the Reds in Cincinnati, checking another stadium off our bucket list. We went out for […] The post Finding joy while living with sarcoidosis is imperative appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
A new study from researchers in Turkey suggests that a ratio taking into account the amount of angiotensin-converting enzyme (ACE) and of lymphocytes, a type of white blood cell — […] The post Researchers ID potential biomarker in sarcoidosis for recurrent disease appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Most people with inflammatory conditions reported overall satisfaction, convenience, and confidence when self-administering Acthar Gel (repository corticotropin injection) through a single-dose, prefilled injector called SelfJect. That’s according to a survey-based […] The post Acthar Gel SelfJect convenient, easy to use: Patient survey appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
This month, I watched the 78th annual Tony Awards, looking forward to performances from the year’s top shows. I’m always hoping to see my new favorites recognized and get ideas […] The post Symptoms of sarcoidosis keep us out of ‘the room where it happens’ appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
A Partner Grant from the Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) will support a research project focused on possible connections between air pollution and outcomes […] The post Grant funds research into air pollution’s effects on sarcoidosis appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The first participants in a Phase 2 clinical trial testing brepocitinib, Roivant’s experimental oral treatment, in adults with cutaneous sarcoidosis have been dosed, and top-line results are expected in the second half […] The post Brepocitinib Phase 2 trial doses first cutaneous sarcoidosis patients appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Methotrexate appears to take longer to start acting, but is no less effective than the corticosteroid prednisone as a first-line treatment for pulmonary sarcoidosis, according to the early findings of an […] The post Methotrexate slower, but effective in treating pulmonary sarcoidosis appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Writer’s block: when you want (or have) to write something but the words just won’t come to you. It could be for a school paper, a business report, a personal […] The post What writer’s block can teach us about symptom management appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
Many people with moderate or severe pulmonary sarcoidosis — the target market for the investigational therapy efzofitimod — are highly burdened by the disease and are dependent on corticosteroids that […] The post Presentations highlight efzofitimod’s potential for pulmonary sarcoidosis appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The prevalence of sarcoidosis, or the proportion of people with the condition in a population, has roughly doubled over the past 30 years in a region in Norway, a large […] The post Prevalence, incidence of sarcoidosis in Norway rose over 30 years appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
April has officially been recognized as Sarcoidosis Awareness Month in the U.S., marking a significant milestone for the community and its advocates, according to the Foundation for Sarcoidosis Research (FSR) […] The post April officially recognized as Sarcoidosis Awareness Month in US appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
More than two dozen mutations that seem to increase the risk of developing sarcoidosis were identified in a new study. Notably, 17 of the 28 mutations hadn’t been linked to […] The post Study identifies 28 gene mutations linked with sarcoidosis risk appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The findings of a new preclinical study in pulmonary sarcoidosis are lending support to the therapeutic potential of efzofitimod, a treatment candidate from Atyr Pharma now being tested in a Phase […] The post Study backs efzofitimod as potential pulmonary sarcoidosis treatment appeared first on Sarcoidosis News.| Sarcoidosis News – The Web's Daily Resource for Sarcoidosis News
The safety and tolerability is being tested of two XTMAB-16 doses against a placebo in patients on a stable corticosteroid dose.| Sarcoidosis News
Sarcoidosis is marked by an over-reactive immune system that begins to attack healthy tissues, creating small clumps of inflammation called granulomas that interfere with and damage any of a number of organs.| Sarcoidosis News
